Market positioning Specialized imaging platform for clinical trials that connects hospitals, experts, and imaging data to automate workflows, offering centralized review and real-time quality control to improve regulatory-ready evidence submission. This positions Collective Minds as a streamlined alternative to fragmented systems, presenting cross-sell opportunities to CROs and sponsors seeking efficiency gains.

Growth signals Recent funding rounds totaling around SEK 84 million and a growing UK presence indicate rapid expansion and increasing validation from investors. This suggests a favorable environment for scaled sales efforts, local partnerships, and expanded service coverage in Europe.

Strategic partnerships Longstanding collaboration with Worldwide Radiology and potential integrations with CROs create opportunities to upsell broader imaging data management, centralized review capabilities, and compliant data handling across multi-site trials.

Global expansion New UK entity and leadership appointment signal readiness to capture international trial activity, enabling sales to global sponsors and multinational sites seeking consistent imaging workflows and regulatory-ready data across regions.

Competitive edge Fully traceable, automated imaging data flow from patient to endpoint reduces fragmentation, accelerates trial timelines, and supports regulatory submissions, offering a compelling value proposition against traditional, manual, or siloed imaging processes.